Dementia Mental and Behavioural Disorders Dementia
Conditions
Interventions
Care homes are randomly allocated to one of two groups.
Intervention group: Staff take part in the manual based training package to teach staff in care home about managing agitation i
Sponsors
University College London (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Care homes inclusion criteria: 1. The minimum number of residents required for a home?s inclusion in the study have dementia (17) 2. Care home is willing to be randomised 3. Care home will commit to allow mandatory training sessions, training staff champions to continue implementation (two per home to take account of possible staff turnover) and changing management procedures, to integrate the new techniques into care 4. Care home will commit to approaching residents and relatives 5. No plans to close over the following year Inclusion criteria for paid carers: 1. Paid carer who provides face to face care for residents, at least some of whom have dementia. 2. Carer willing to complete the questionnaires about residents with dementia whom they know well 3. Carer willing to answer questions about their own coping Inclusion criteria for residents with dementia: 1. Dementia diagnosis according to Noticeable Problems Checklist or known dementia diagnosis Inclusion criteria for family carer: 1. Identifies themselves as the primary family carer for a resident in the home who either consents to the study or if the resident does not have capacity to consent to the study then the family carer has agreed that they will be in the study 2. See their relative with dementia at least monthly
Exclusion criteria
Exclusion criteria: Exclusion criteria for care homes: Less than 70% of the staff consent to the study after the care home manager has agreed to the study but before randomisation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cohen-Mansfield Agitation Inventory (CMAI) total is measured at 8 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cost effectiveness in terms of agitation (CMAI) is measured at 8 months 2. Cost effectiveness in terms of QALYS is measured at 8 months 3. Quality of life of residents in the intervention group compared to the control group is measured at 8 months 4. Reducation in clinically significant agitation(CMAI>45)in intervention group compared to control group is measured at 8 months 5. Reduction in neuropsychiatric symptoms overall in intervention group compared to control group is measured at 8 months | — |
Countries
United Kingdom
Contacts
Public ContactAnne Laybourne
Outcome results
None listed